Article Versions Notes

Park S, Jo S-H, Kim J-H, Kim S-Y, Ha JD, Hwang JY, Lee MY, Kang JS, Han T-S, Park SG, et al. Combination Treatment with GSK126 and Pomalidomide Induces B-Cell Differentiation in EZH2 Gain-of-Function Mutant Diffuse Large B-Cell Lymphoma. Cancers. 2020; 12(9):2541. https://doi.org/10.3390/cancers12092541

Park, Sungryul, Seung-Hyun Jo, Jong-Hwan Kim, Seon-Young Kim, Jae Du Ha, Jong Yeon Hwang, Myeong Youl Lee, Jong Soon Kang, Tae-Su Han, Sung Goo Park, and et al. 2020. "Combination Treatment with GSK126 and Pomalidomide Induces B-Cell Differentiation in EZH2 Gain-of-Function Mutant Diffuse Large B-Cell Lymphoma" Cancers 12, no. 9: 2541. https://doi.org/10.3390/cancers12092541

Park, S., Jo, S.-H., Kim, J.-H., Kim, S.-Y., Ha, J. D., Hwang, J. Y., Lee, M. Y., Kang, J. S., Han, T.-S., Park, S. G., Kim, S., Park, B. C., & Kim, J.-H. (2020). Combination Treatment with GSK126 and Pomalidomide Induces B-Cell Differentiation in EZH2 Gain-of-Function Mutant Diffuse Large B-Cell Lymphoma. Cancers, 12(9), 2541. https://doi.org/10.3390/cancers12092541